Diabetes Medicine Victoza in Clinical Trial for Parkinson’s Disease Treatment
Victoza (liraglutide), a drug therapy for type 2 diabetes, is currently being evaluated in an ongoing clinical study to slow or stop the progression of Parkinson’s disease. This study is developed by the Linked Clinical Trials (LCT) initiative from The Cure Parkinson’s Trust in the United Kingdom, together with the Van Andel…